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Abstract  
Caffeinated and decaffeinated coffee consumption has increasingly been linked to reduced 
risks of type 2 diabetes. The condition is characterised by insulin resistance and pancreatic 
beta cell loss and dysfunction, leading to hyperglycaemia. Recent research has indicated 
that coffee components such as chlorogenic acid derivatives and cafestol positively modify 
the regulation of blood glucose levels in peripheral tissues. Taking into consideration 
bioavailability of coffee bioactives, this mini-review evaluates the pros and cons of individual 
components and their combinations and highlights some of their significant effects on 
insulin secretion. Although the loss and/or dysfunction of beta cells is a key element in type 
2 diabetes, little is known about the impact of coffee components on the regulation of beta 
cell mass, including survival under conditions of hyperglycaemia, lipotoxicity and 
inflammation. Further investigations are warranted in particular with regards to use of 
physiologically relevant concentrations and conjugated forms of the bioactive components. 
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1. Introduction 
The increasing incidence of type 2 diabetes (T2D) constitutes a significant health issue with 
the condition being one of the top 10 causes of death worldwide (World Health 
Organisation (WHO), 2017). It is therefore imperative to find solutions to the management 
and prevention of diabetes, and potential beneficial effects of natural compounds have 
become a point of focus in medical research. However, despite reports of their potential 
preventive role in diabetes, natural compounds of interest are not necessarily easily 
accessible for the general consumer as part of a regular diet (such as for example a range of 
plant components traditionally used in Chinese medicine, e.g. extract of White Kwao Krua 
(Pueraria Lobata, (Xiong, Sun, Gan, Yang, & Xu, 2006) or puerarin from Rhizoma Coptidis (E. 
K. Kim et al., 2007). It is therefore relevant to assess whether habitually consumed 
compounds found in regular food and drink may indeed provide readily available and novel 
benefits.   
 
Coffee is among one of the most frequently consumed drinks worldwide and regular, long-
term consumption of both caffeinated and de-caffeinated coffee has been shown to reduce 
the risk of T2D (Bhupathiraju et al., 2013; Ding, Bhupathiraju, Satija, van Dam, & Hu, 2014; 
Jiang, Zhang, & Jiang, 2014; Odegaard et al., 2008; van Dam & Hu, 2005). In addition to 
caffeine, coffee contains a variety of other compounds. One such group is chlorogenic acids 
(CGAs), a family of polyphenolic compounds which in other disease settings exhibits 
protective properties and in T2D has been suggested to affect a number of factors relevant 
for the regulation of blood glucose levels, including intestinal glucose uptake, hepatic 
glucose output and oxidative stress in the liver (Santos & Lima, 2016).  
 
T2D is a complex disease which is characterised by insulin resistance in the insulin target 
tissues and insulin secretory dysfunction with significant loss of functional beta cells in the 
pancreas leading to hyperglycaemia. So far, studies investigating the association between 
the potential effects of coffee derivatives and T2D have focused on roles in peripheral 
tissues, such as improving insulin sensitivity and to a lesser extent a central effect on insulin 
secretion. The aim of this narrative review is to evaluate current knowledge and the most 
updated evidence on the effect of coffee compounds and in particular CGAs on T2D risk 
with specific focus on pancreatic islet function and consequent impact on insulin release 
and beta cell survival. 
 
2. Bioavailability of major coffee components and their metabolites  
Coffee is a complex mixture of chemical compounds (table 1) and its composition varies 
according to the species of coffee bean and the roasting and brewing processes involved. 
Caffeine, a methylxanthine, is the most well-known component, but the beverage also 
contains a range of other components, some of which are minerals (e.g. magnesium and 
potassium), diterpenes such as cafestol and kahweol, the plant alkaloid trigonelline as well 
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as more than a thousand phenolic compounds. Of these, chlorogenic acids (CGAs) are the 
most prevailing (Ludwig, Paz de Pena, Concepcion, & Alan, 2013; Moon & Shibamoto, 2009).  
 
Caffeine intake per serving ranges between 51-322 mg (Crozier, Stalmach, Lean, & Crozier, 
2012). The compound is readily absorbed in the stomach and small intestine and is 
distributed throughout the body via the circulation but is also further metabolized in the 
liver to a range of metabolic derivatives (Arnaud, 2011). Depending on variety, roasting and 
coffee making procedure a coffee serving contains 40-110 mg trigonelline but in contrast to 
caffeine, there is limited production of secondary metabolites from the compound although 
it is also readily detected in plasma samples in the micromolar range (Lang et al., 2013).  
Diterpenes are found as fatty acyl esters in coffee and are known to increase cholesterol 
plasma levels. Their content is reduced in coffee by preparation methods involving paper or 
fabric (‘sock’) filtration. Thus Naidoo et al. (2011) found that unfiltered coffee such as boiled 
Scandinavian coffee or Turkish/Greek coffee contained 0.4-9.68 mg/cup of cafestol and 
0.08-11.68 mg/cup kahweol, respectively, whereas filtered coffee contained much less (e.g.  
Singapore coffee: 0.02-0.23 mg/cup cafestol and 0.01-0.06 mg/cup kahweol, respectively, 
Naidoo et al., 2011). 
 
Caffeic acid, and its derivatives, the CGAs, are the most common phenolic compounds in 
coffee and Richelle et al. (2001) reported that a single serving of the beverage contains 
between 15 and 325 mg/cup depending on type of coffee, roasting and brewing methods, 
although there is some variation between different studies regarding these values (e.g. 
Crozier et al., 2012; Mills, Oruna-Concha, Mottram, Gibson, & Spencer, 2013; Stalmach et 
al., 2009). CGAs are esters of caffeic or ferulic acid and quinic acid, and a wide variety of 
isomers exist in the CGA family, of which 5-caffeoyl-quinic acid (5-CQA) is the most 
abundant in coffee reviewed in Cano-Marquina, Tarin, & Cano, 2013). 
 
In order to exhibit any physiological effect on metabolic regulation including islet function, 
the bioavailability of the CGAs is of paramount importance. A number of studies has 
measured physiologically relevant concentrations of CGAs and particularly their metabolites 
in the circulation in both rodents and man, but also highlighted the fact that there are high 
levels of variation between individuals, and that different isomers are absorbed and 
metabolized to varying degree (Farah, Monteiro, Donangelo, & Lafay, 2008; Gonthier, 
Verny, Besson, Remesy, & Scalbert, 2003; Mills et al., 2013; Monteiro, Farah, Perrone, 
Trugo, & Donangelo, 2007; Stalmach, Williamson, & Crozier, 2014).  
 
In the gastrointestinal tract a small proportion of ingested CGAs is hydrolysed to caffeic (and 
ferulic) acid by enzymatic activity and absorbed in the small intestine via monocarboxylic 
acid transporters or other means of carrier-mediated transport. In addition passive diffusion 
has also been proposed as a potential mechanism (El-Seedi et al., 2012; Zhao & 
Moghadasian, 2008). The compounds are subsequently conjugated and likely constitute the 
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initial wave of increased plasma concentrations of CGAs following a CGA-rich intake 
(Stalmach et al., 2014). Absorption and metabolism of phenolic acids also take place in the 
large intestine, where the microbiota plays an important role in further catabolizing and 
modifying the precursor compounds (Anhê et al., 2013; Olthof, Hollman, Buijsman, van 
Amelsvoort, & Katan, 2003). Some in vitro and in vivo studies have shown the potential 
prebiotic effects of phenolic acids to increase the population of healthy beneficial bacteria 
such as bifidobacteria whilst decreasing adverse populations (Chacar et al., 2018; Duncan et 
al., 2016; Xie et al., 2017). Thus the resulting metabolic end products from the large 
intestine are likely to be quantitatively more important contributors to the circulating levels 
of physiologically relevant metabolites than those from the small intestine and contribute to 
a later peak of CGAs in the blood (Gonthier et al., 2003; Renouf et al., 2010; Stalmach et al., 
2014).  
 
3. Impact of bioactive coffee components on insulin resistance and other non-pancreatic 
aspects of blood glucose control 
The key issue in diabetes, whether type 1 or type 2, is the derangement of blood glucose 
homeostasis with subsequent hyperglycaemia. In T2D this is caused by a combination of 
insulin resistance in the insulin target tissues and insulin secretory dysfunction in pancreatic 
beta cells. De-regulated blood glucose levels have acute health consequences, but also lead 
to long-term complications such as neuropathy, nephropathy, retinopathy and increased 
risk of cardiovascular disease. Blood glucose control is therefore sought therapeutically via 
improvement of insulin sensitivity in muscle and adipose tissues with concomitant changes 
in glucose uptake into the cells and via enhancement and preservation of insulin secretion 
from the pancreatic beta cells. However, other means of regulating glucose homeostasis are 
also of interest, for example at the level of glucose uptake from the intestine and 
production of glucose in the liver. Beta cell function is the main focus of this review, and the 
role of coffee components in peripheral tissues has been reviewed elsewhere (see for 
example Adisakwattana, 2017; Tajik, Tajik, Mack, & Enck, 2017), therefore only a brief 
summary will be presented to provide context (see figure 1).  
A number of human studies (e.g. Agardh et al., 2004; K. Kim, Kim, & Park, 2016; Lecoultre et 
al., 2014; Pham et al., 2015; Sarria et al., 2016)  suggest that coffee consumption leads to a 
reduction in insulin resistance thus supporting the notion that coffee components can 
directly modify insulin sensitivity in peripheral tissues although this does not specify the 
specific points of potential action (please refer to figure 1). The findings in humans are 
consistent with animal studies such as for example that of Shokouh et al. (2017), who very 
recently showed that a twelve week diet intervention with a combination of caffeic acid, 
trigonelline and cafestol led to improved insulin sensitivity in a rat model of the metabolic 
syndrome. Ma, Gao, & Liu (2015) similarly reported of reduced insulin resistance and 
attenuated inflammation of liver and white tissue in C57BL/6 mice fed a high fat diet for 15 
weeks following administration of CGAs twice weekly. Intraperitoneal administration of CGA 
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in Leprdb/db mice (an animal model of type 2 diabetes) was specifically shown to reduce 
hepatic glucose-6-phosphatase expression and activity and thus gluconeogenesis in liver in 
addition to inhibiting fatty acid synthesis and improving muscle glucose uptake (Ong, Hsu, & 
Tan, 2013), thus providing some information on potential underlying peripheral mechanisms 
of action.  
Some in vitro studies supported the effect of CGAs and derivatives on glucose uptake in 
muscle; this was, however, dependent on type of derivative and with relatively high 
concentrations providing moderate effects (Azay-Milhau et al., 2013; Tousch et al., 2008). 
More significant changes regarding glucose uptake were observed in a liver cell line (Huang, 
Shen, & Wu, 2009). In addition Mellbye et al. reported of clear beneficial effects on glucose 
uptake in a muscle cells by another coffee component, cafestol (Mellbye, Jeppesen, 
Hermansen, & Gregersen, 2015). 
The effect of caffeine on insulin sensitivity depends on type of administration, where acute 
intake has in fact been shown to induce insulin resistance in rodents and man (Dewar & 
Heuberger, 2017; Greer, Hudson, Ross, & Graham, 2001; Sacramento et al., 2015; Shi, Xue, 
Liang, Zhao, & Zhang, 2016), whereas chronic intake prevented diet-induced insulin 
resistance in rats (Conde et al., 2012), possibly due to the development of caffeine 
tolerance. 
Other reported T2D-related outcomes with coffee compounds include an inhibitory effect of 
CGAs on glucose uptake in the intestine and stimulation of glucagon-like-peptide 1 (GLP1) 
secretion from gastrointestinal cells, which in turn can modify gastric emptying and 
stimulate insulin secretion (Fujii, Osaki, Hase, & Shimotoyodome, 2015; Johnston, Clifford, & 
Morgan, 2003).  However, contradictory results exist regarding the impact on GLP1 and thus 
indirectly on insulin release (Tunnicliffe, Eller, Reimer, Hittel, & Shearer, 2011). 
4. Coffee and pancreatic islet function in type 2 diabetes 
The hormone insulin is produced by beta cells in the pancreatic islets of Langerhans. 
Hyperinsulinemia is often seen as a response to insulin resistance and is a compensatory 
mechanism where the pancreatic beta cells produce more insulin to counteract the reduced 
insulin sensitivity of the peripheral tissues. In addition to this increased demand for 
hormone production, the cells are also persistently exposed to a local environment of 
inflammation and (gluco)lipotoxicity during the development of T2D and with time this has 
detrimental effects on beta cell function and mass (Chang-Chen, Mullur, & Bernal-Mizrachi, 
2008a). Protection and/or improvement of beta cell survival under these conditions is 
therefore a key area of research in order to postpone or indeed prevent beta cell loss and 
subsequent reduction in secretory capacity.   
4.1 Human studies on beta cell function 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
7 
 
There is limited evidence for the role of coffee derivatives on beta cell function and insulin 
secretion from human studies. Whereas a range of findings suggest that coffee consumption 
reduces the relative risk of insulin resistance (as indirectly measured by the HOMA-IR index) 
in healthy (Rebello et al., 2011), non-diabetic overweight (Wedick et al., 2011) and obese 
individuals (Pham et al., 2015), these studies did not observe any changes in beta cell 
function when measured indirectly by the HOMA-beta index assessment. However, the 
population studies by Rebello et al. (2011) and Pham et al. (2015) did not distinguish 
between caffeinated and decaffeinated coffee consumption, in contrast to the much 
smaller, randomized parallel-arm intervention study by Wedick et al. (2011). It is therefore 
possible that potential separate effects of caffeine and non-caffeine components of coffee 
went unnoticed in these studies.  
This notion is supported by a cross-sectional study (Loopstra-Masters, Haffner, Lorenzo, 
Wagenknecht, & Hanley, 2011) involving 954 multi-ethic non-diabetic individuals from the 
Insulin Resistance Atherosclerosis Study (IRAS). Results from this study showed that 
caffeinated coffee intake was associated with an increase in peripheral insulin sensitivity 
with no effect on the acute insulin release, whereas decaffeinated coffee positively affected 
beta cell function, as measured by multiple regression analyses of the acute insulin response 
and ratios of proinsulin and C-peptides. 
In addition, the health status of study participants is likely to be important in this context. 
Thus Agardh et al. (2004) found that coffee consumption (>5 cups/d) reduced the relative 
risk of type 2 diabetes and impaired glucose tolerance in a Swedish population of middle-
aged, healthy individuals as has been reported elsewhere in other healthy population 
groups. However, they also showed that increased coffee intake was inversely associated 
with reduced beta cell function in addition to any effect on insulin sensitivity specifically in 
individuals diagnosed with type 2 diabetes. Thus men diagnosed with T2D consuming >5 
cups per day showed 60 and 70% reduction in the relative risk of insulin resistance and low 
beta cell function, respectively vs men consuming 2 cups or less, whereas in women the 
relative risks were 70 and 50%, respectively. This suggests firstly, that coffee components 
may be of particular importance not only for risk reduction, but also for management of the 
condition and secondly, that under those circumstances, beta cell function was impacted by 
coffee. Studies like this cannot, however, unambiguously clarify whether such effects are 
indirectly caused by changes in peripheral parameters or by direct effects of coffee 
components on pancreatic islet function. For that purpose in vitro and ex vivo experiments 
with whole pancreata, isolated islets and/or pancreatic beta cell lines are of particular value 
as experimental research models. 
4.2 In vitro research models 
The insulin-producing beta cells are located in small, three-dimensional clusters of cells, the 
islets of Langerhans, and in a human pancreas there are approximately 1 million islets 
distributed in the exocrine tissue of the pancreas, in the size range of 50-500 μm (Pipeleers, 
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Kiekens, & In't Veld, 1992). The islets contain other types of cells in addition to beta cells, of 
which glucagon-secreting alpha cells and somatostatin-producing delta cells are the most 
important. These cells interact to modify and regulate the overall hormonal output from the 
islet (Hauge-Evans et al., 2009; Van Schravendijk et al., 1985), and to fully understand the 
role of coffee derivatives in the regulation of insulin secretion and beta cell function in 
general, it is therefore important firstly to assess the impact of these compounds on other 
islet cell types and secondly to employ research models where non-beta cell input has been 
eliminated or minimised.  
Pancreatic beta cell lines constitute initial useful models for investigating beta cell function, 
particularly if the cells are configured as three-dimensional ‘pseudoislets’ (Hauge-Evans, 
Squires, Persaud, & Jones, 1999), which facilitate a higher degree of cell-cell contact similar 
to that of the primary micro-organs. We have thus previously shown that the three-
dimensional structure of pseudoislets from the pancreatic MIN6 beta cell line conveys 
superior functionality compared to MIN6 cells configured as two-dimensional monolayers, 
whilst at the same time enabling specific studies on beta cell function only (Hauge-Evans et 
al., 1999). Beta cell lines do, however, have limitations compared to primary islet tissue with 
regards to issues such as levels of insulin content and secretory response (Persaud, Hauge-
Evans, & Jones, 2014), and it is therefore paramount to support any initial findings with 
studies involving primary islets. Isolated islets furthermore provide a research model in 
which the impact of target compounds on insulin secretion and overall beta cell function 
can be investigated under conditions where factors from both peripheral and central tissues 
are excluded and therefore do not mask any direct action on the beta cells. For this specific 
purpose they are therefore more informative than in vivo studies, although findings from in 
vitro studies need to be followed up by in vivo studies to confirm their physiological 
relevance. In addition to cell line and isolated islet studies, ex vivo experiments with 
perfusion of whole, in situ isolated pancreata are informative for assessment of islet 
hormone secretion, incorporating local factors within the pancreatic exocrine tissue but 
excluding effects of other organs. However some interaction with the duodenum cannot be 
excluded (Scratcherd & Case, 1973). 
When considering the importance of coffee derivatives on beta cell function, a potential 
impact on beta cell viability have to date often been overlooked even if the maintenance of 
adequate beta cell mass is essential for maintaining sufficient release of insulin. Thus, both 
assessments on insulin secretion and overall regulation of beta cell mass including beta cell 
survival and proliferation is required to evaluate the impact of coffee derivatives, in 
particular in the context of the development of T2D, where the islet is exposed to a range of 
cellular factors negatively impacting cell survival. 
4.3 Coffee compounds and insulin secretion 
Caffeine has been known to stimulate glucose-induced insulin secretion for a long time. The 
effect is thought to be mediated both via activation of ryanodine receptors affecting 
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intracellular Ca2+ concentrations and via inhibition of antagonistic effects of cAMP-
phosphodiesterases on hormone release (Bruton et al., 2003; Sams & Montague, 1972). 
In contrast, there are a limited number of studies directly investigating the role of non-
caffeine coffee derivatives with regard to insulin secretion. Mellbye et al. (Mellbye et al., 
2015) performed an in vitro study with the rat insulinoma beta cell line INS1E, where they 
investigated acute insulin release in response to selected compounds representative of the 
main components in coffee, that is, cafestol, caffeic acid, chlorogenic acid, trigonelline, 
secoisolariciresinol and oxokahweol. Only cafestol and caffeic acid modestly, but 
significantly, stimulated glucose-induced insulin release and also improved release following 
prolonged exposure to the two coffee components at metabolically relevant concentrations 
(10-10-10-8mol/l). This investigation was followed up by an in vivo study in the KKay animal 
model of type 2 diabetes (Tomino, 2012), where animals received a low or high cafestol-
containing diet for ten weeks, leading to reduced fasting glucose levels, increased insulin 
sensitivity and significantly improved insulin secretion from isolated islets (Mellbye et al., 
2017). Unfortunately no oral glucose tolerance test was performed to give specific 
information on both glucose levels and insulin release following a glucose challenge. 
Kafestol content in coffee is reduced by paper filtration, and it is questionable whether the 
concentrations used in the rodent model (when translated to human parameters) compare 
to circulatory levels following consumption in the majority of the general population and 
therefore can constitute a significant explanatory factor for the observed beneficial effects 
of coffee in population studies.  Nonetheless, the study provided important evidence of a 
potential therapeutic role of the coffee derivative although at pharmacologically rather than 
physiologically relevant concentrations. 
The beneficial, but moderate effect of caffeic acid on acute insulin secretion reported by 
(Mellbye et al., 2015) was consistent with the findings of Bhattachaya et al. (2014), who also 
showed that chronic exposure to the phenolic acid further enhanced the secretory response 
from INS1E beta cells. This effect was maintained following chronic treatment with high 
glucose concentrations, suggesting a protective effect of the compound on beta cell survival 
when exposed to stressful conditions typical of type 2 diabetes. Unfortunately these 
findings were not confirmed in primary islets. Azay-Milhau et al. (2013) did not find any 
stimulatory effect of caffeic acid on insulin secretion, probably due to the non-stimulatory 
glucose concentrations used in these experiments. However, an extract of chicoric acid, 
another hydroxycinnamic acid (2,3-dicaffeoltartaric acid), did stimulate release at these 
glucose concentrations, confirming previous results on chicoric acid from this research 
group (Tousch et al., 2008). 
There is thus conflicting evidence for an effect of caffeic acid on insulin secretion and also 
whether the phenolic acids tested modify secretion in a glucose-dependent or independent 
manner. In addition, the importance of conjugates was not evaluated, even though 
Stalmach et al. (2009; 2014) suggest that caffeic acid-3’-O-sulphate and ferulic-4’-O-sulfate 
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are the main metabolites in the circulation from the small intestine (in the range of 65-126 
nmol/l). These studies and similarly findings by Renouf et al. (2010) also showed that 
dihydrocaffeic and dihydroferulic acids and their sulphate-conjugated derivatives were 
much more abundant than the parent compounds in plasma from human subjects following 
coffee intake (1-500 nmol/l), highlighting the importance of microbiota-derived catabolites. 
Ludwig et al. (2013) similarly found that catabolism of coffee CGAs by microbiota from 
human faecal samples in vitro only transiently led to the production of caffeic and ferulic 
acid, whereas the main catabolic end products were dihydrocaffeic, dihydroferulic and 3-(3’-
hydroxyphenyl)propionic acid, making up approximately 80% of the total metabolites 
produced.  
Of interest here are also the studies by Adisakwattana, Moonsan, & Yibchok-Anun (2008), 
who investigated the role of cinnamic acid and hydroxy- or methoxy-cinnamic acid 
derivatives as well as ferulic and isoferulic acid in the regulation of insulin secretion. It was 
clear from their studies that the position of the hydroxy- and methoxy- groups influenced 
the secretagogue potential of the different compounds with m-hydroxycinnamic, p-
methoxycinnamic and ferulic acid stimulating insulin release from INS1E cells and perifused 
pancreas at low glucose concentrations whereas other derivatives were less effective. 
Unfortunately the concentrations used were predominantly high (100 μmol/l) compared to 
physiologically relevant concentrations, although the same group in a later study reported 
that 10 μmol/l p-methoxycinnamic acid further enhanced glucose-induced insulin release 
from the perfused pancreas (Yibchok-anun, Adisakwattana, Moonsan, & Hsu, 2008). More 
recently, the parent compound, cinnamic acid, improved glucose tolerance in vivo and 
increased insulin secretion in vitro from isolated islets, however, again at high 
concentrations (50, 100 and 200 μmol/l, Hafizur et al., 2015). There is therefore a current 
need for future studies which investigates the role of coffee-derived phenolic acids, where 
physiologically relevant metabolites, rather than parent compounds, are investigated at 
concentrations which are comparable with circulating levels in the body following coffee 
consumption.  
4.4 Coffee compounds and beta cell survival 
As mentioned, development of type 2 diabetes is associated with the deterioration of beta 
cell function and/or mass and it is therefore relevant not only to investigate how coffee-
derived compounds affect insulin secretion directly, but also whether they may convey 
potential protective properties to the pancreatic islet, thus delaying or minimising the 
detrimental effects of cellular stresses such as gluco- and lipotoxicity, oxidative stress and 
inflammation associated with the condition (Chang-Chen, Mullur, & Bernal-Mizrachi, 2008b; 
Cnop et al., 2005; Marchetti, Dotta, Lauro, & Purrello, 2008; Poitout & Robertson, 2008). 
Whereas inflammation for example may be reduced systemically via action of coffee 
compounds on other tissues, the key question here is whether there is a direct, protective 
effect on the pancreatic beta cell. Beta cell mass is regulated by cell death, but also by cell 
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replication and hypertrophy (Bonner-Weir et al., 2010). The role of coffee derivatives in all 
these cellular processes and the underlying cellular mechanisms are therefore of interest. 
One coffee component, trigonelline, a plant alkaloid, reportedly exhibit antioxidant 
properties in pancreatic tissue (Zhou, Zhou, & Zeng, 2013). CGAs also harbour strong 
antioxidant activities in vitro although the relative importance in vivo compared to other 
dietary antioxidants have been questioned in recent years (Ludwig, Clifford, Lean, Ashihara, 
& Crozier, 2014). It is thus suggested that the cellular mode of action for CGAs and 
derivatives may involve direct modulation of intracellular pathways leading for example to 
changes in gene expression (Miene, Weise, & Glei, 2011). Coffee components may therefore 
not only benefit beta cells through their antioxidant properties but also via alternative 
pathways.  
 
Streptozotocin (STZ)-induced diabetes is often used as an animal model for type 1 rather 
than type 2 diabetes, since injection of high doses STZ (>50mg/kg) leads to destruction of 
beta cells, however, a combination of low dose STZ and high fat diet has been proposed as a 
model for type 2 diabetes (Srinivasan, Viswanad, Asrat, Kaul, & Ramarao, 2005). Rodent 
animal studies of STZ alone or STZ and high fat diet-induced diabetes showed that oral 
administration of either ferulic acid (eight weeks, Roy, Metya, Sannigrahi, Rahaman, & 
Ahmed, 2013) or trigonelline (four weeks, Zhou et al., 2013) led to reduction in circulating 
blood glucose and lipid levels. In addition, a range of oxidative stress markers was improved 
in pancreatic tissue with subsequent decrease in levels of pro-inflammatory islet cytokines, 
beta cell apoptosis and increase in islet insulin content. This could implicate a direct effect 
of the compounds on the pancreatic islets. However, it cannot be excluded that the 
improved islet parameters were indirectly caused by a reduction of circulating stress factors 
(e.g. lipids) leading to localised reduction in oxidative stress levels in pancreatic tissues. 
 
A wide range of plant polyphenols has been investigated with regard to potential beneficial 
effects in type 2 diabetes including assessment of underlying molecular mechanisms of 
action (e.g. quercetin, Carrasco-Pozo et al., 2016). There are, however, to our knowledge 
few studies specifically exploring the direct impact of coffee derivatives on the regulation of 
beta cell mass, either with regards to survival under stressful conditions typical of the 
development of type 2 diabetes, or concerning proliferative/hypertrophic properties of the 
beta cells in normal, (gluco)lipotoxic or inflammatory environments. Bhattacharya et al. 
(2014) mainly investigated insulin secretion in vitro from INS1E beta cells, but also found 
that caffeic acid under conditions of hyperglycaemia caused a decrease in the mRNA 
expression of the pro-apoptotic caspase 3 and Bax proteins and increased mRNA levels of 
Hsp70, suggesting a role of this particular derivative in the regulation of beta cell survival. 
Cheng et al. (2011) found that the detrimental effect on beta cells of amyloid polypeptide 
formation in type 2 diabetes (Butler, Janson, Soeller, & Butler, 2003), was decreased in vitro 
by caffeic acid and to a much lesser extent CGAs and caffeine. Similarly, Sompong et al 
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(2017) found that beta cell death induced in vitro by oxidative DNA damage was partly 
reversed by pre-treatment with ferulic acid – however, only at high concentrations (100 
μmol/l).  The scarcity of studies in this area therefore suggest that further research is 
needed to establish whether bioactive coffee compounds at physiologically relevant 
concentrations do convey protection for the beta cells, and if so, which underlying 
mechanisms are involved.  
 
5. Conclusion 
 
There is growing evidence from human studies supporting an important, protective role of 
coffee components in the aetiology of type 2 diabetes. This holds true for both caffeinated 
and decaffeinated coffee, suggesting that non-caffeine bioactives are of particular interest. 
Findings indicate that components such as CGA derivatives and cafestol positively modify 
the regulation of blood glucose levels via a number of different actions in peripheral tissues. 
The impact on beta cell function is difficult to assess directly in human studies, and there is 
therefore a need for more mechanistic in vitro investigations into the role of both individual 
coffee components and their combinations. Some studies report on modest, but significant 
effects on insulin secretion although further investigations are warranted in particular with 
regards to use of physiologically relevant concentrations and conjugated forms of the 
bioactive components. Although the loss and/or dysfunction of beta cells is a key 
component in the development of T2D and some coffee components have been shown to 
have protective properties in other disease settings, very little is known specifically about 
the impact on factors regulating beta cell mass, including survival under conditions of 
hyperglycaemia, lipotoxicity and inflammation. Further and larger studies are therefore 
required in this field before any recommendations can be made. 
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Figure legend: 
Figure 1: Possible mechanistic points of action for control of blood glucose by bioactive 
non-caffeine coffee compounds.  
Glucose homeostasis is maintained via a number of insulin-dependent and independent 
mechanisms in peripheral tissues and in the pancreatic islets. The main mechanisms to be 
affected by coffee compounds (indicated in brackets) are highlighted. Inhibition of α-
amylase and α-glucosidase enzymatic activity in the oral cavity and small intestine and the 
intestinal sodium-dependent glucose transporter (SLGT1) slows down carbohydrate 
digestion and glucose absorption into the circulation. Glucose uptake from the blood stream 
is increased by CGAs and/or derivatives in insulin-sensitive muscle and adipose tissues via 
upregulation of glucose transporter GLUT4. In the liver CGAs modulate expression and 
enzymatic activity of glucose-6-phosphatase and other components of the metabolic 
pathways leading to gluconeogenesis and subsequent glucose release. Insulin sensitivity in 
peripheral tissues is decreased by subclinical levels of circulating cytokines; however, 
inflammation is reduced by CGAs and metabolites. These findings are based on findings 
from either in vitro or in vivo studies. Please see reviews by (Santos & Lima, 2016) and 
(Akash, Rehman, & Chen, 2014) for more detail. In the pancreas, insulin secretion is 
stimulated by cafestol and potentially also CGAs and derivatives, the latter of which also 
reduce oxidative stress in the pancreas with subsequent increase in beta cell survival (please 
see text). Note that effects of coffee compounds on lipid metabolism are not included in the 
figure. CGAs and derivatives are collectively indicated in figure as CGAs. Schematic modified 
from (Guasch-Ferre, Merino, Sun, Fito, & Salas-Salvado, 2017). 
 
Table legend: 
Table 1. Estimated ranges of coffee components in green beans, roasted beans and per 
cup/serving, adapted from previous studies. 1(Caprioli et al., 2014), 2(Crozier et al., 2012), 3(Farah & 
Duarte, 2015), 
4
(Godos et al., 2014), 
5
(Heckman, Weil, & Gonzalez de Mejia, 2010), 
6
(Ludwig et al., 2014), 
7
(Maeztu et al., 2001), 
8
(McCusker, Goldberger, & Cone, 2003), 
9
(Naidoo et al., 2011), 
10
(Oliveira et al., 2012), 
11
(Poisson, Dunkel, & Hofmann, 2017), 
12
(Santos & Lima, 2016). 
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Contents per cup/serving 
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- Monosaccharide (e.g. fructose, 
glucose, galactose,   arabinose, 
traces) 
 
- Oligosaccharide (e.g. Sucrose, 
raffinose, stachyose) 
 
- Polysaccharide (e.g. mannose, 
arabinose, glucose) 
 
 
40-65%11,12      
 
 
1-2%11    
 
 
 
4.0-8.0%11 
 
 
49.8-54.4%11 
 
38-42%12 
 
 
N/A11 
 
 
 
None11 
 
 
38-42%11 
 
- 
 
 
- 
 
 
 
- 
 
 
- 
 
2. Nitrogen (N) containing compounds 
- Proteins 
 
 
- Caffeine  
 
 
 
 
 
 
 
 
 
- Trigonelline 
 
 
 
10%11 
11%12 
 
1.2-2.2%11,12 
3.85-4.29 mg/g4 
 
 
 
 
 
 
 
 
0.6-1.0%4,6 
 
 
7.5%11 
10%2 
 
1.3-2.4%11,12 
4.74-9.44 mg/g4 
 
 
 
 
 
 
 
 
0.2-0.9 mg/g6 
 
 
- 
- 
 
Caffeinated coffees 
  Espresso 
  51-330 mg/28-50 ml 1,2,4,8   
 
  Brew 
  102-200 mg/220 ml5 
 
Decaffeinated coffee 
  17.7 mg/240 ml8 
  
40-110 mg/serving6 
Table
 
3. Lipids 
 
Diterpene 
- Cafestol 
 
 
 
- Kahweol 
 
   
 
10-16%12 
 
 
0.045-0.19mg/g4 
 
 
 
0.04-0.090 mg/g4 
 
11-17%12 
 
 
Arabica beans = 0.3-0.7%4 
Rubusta beans = ~0.1-0.3%4 
 
 
arabica beans = 0.1-0.3%4  
rubusta beans = <0.01%4 
 
- 
 
 
Espresso: 0.16-2.32 mg/ 120 ml7,9 
 
Filtered coffee: 0.02 mg/150 ml4 
 
Espresso: 0.09-0.18 mg/50 ml4 
                  0.16-3.12mg/120ml7,9 
 
Filtered coffee: 0.02 mg/150 ml4 
 
 
4. Chlorogenic acids 
 
 
0.8-11.9%4 
 
 
Commercial ground roasted coffee: 
0.003-0.035/gm3  
 
Espresso: 96-111 mg/30 ml7 
Filtered coffee: 143-247mg/130 ml7 
 
5. Melanoidins 
 
None4 
 
0.072 mg/g4 
 
 
Espresso: 116 mg/50 ml4 
Filtered coffee: 270 mg/150 ml4 
 
 
9.  Minerals 
 
- Na 
 
- K 
 
- Mg 
 
- Mn 
 
4.2-4.4%11 
 
4.5-4.7%11 
 
 
 
25.9-289.4 mg/100ml10 
 
3716.6-6149.6 mg/100ml10 
 
306.9-546.8 mg/100ml10 
 
0.99-3.99 mg/100ml10 
 
 
Oral cavity: 
↓ α-amylase (CGAs) 
Liver: 
↓ glucose-6-phosphatase (CGAs) 
↓Oxidative stress (Cafestol, CGAs) 
↓ Inflammation  
     (CGAs, trigonelline) 
Small intestine: 
↓ α-Amylase (CGAs) 
↓ α-glucosidase (CGAs) 
↓ SLGT1 (CGAs) Muscle: 
↑GLUT4 translocation 
(CGAs, cafestol) 
↓ Inflammation (CGAs) 
Adipose tissue: 
↑GLUT4 (CGAs) 
↓ Inflammation (CGAs) 
Pancreas: 
↑ Insulin secretion (Cafestol, CGAs?) 
↓ Oxidative stress (Trigonelline, CGAs?) 
↑ Beta cell survival (CGAs?) 
Large intestine: 
Modulation of microbiota 
composition 
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